LON:IBT International Biotechnology (IBT) Share Price, News & Analysis GBX 610 -4.00 (-0.65%) As of 08:04 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock About International Biotechnology Stock (LON:IBT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get IBT alerts:Sign Up Key Stats Today's Range 608▼ 61250-Day Range 614▼ 73252-Week Range 596▼ 736Volume160,186 shsAverage Volume72,334 shsMarket Capitalization£219.12 millionP/E Ratio5.82Dividend Yield4.75%Price TargetN/AConsensus RatingN/A Company OverviewThe Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies. The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology. Investments may also be made in related sectors such as medical devices and healthcare services. While the Company’s portfolio is held as one pool of assets, for operational purposes there is a quoted portfolio and an unquoted portfolio. The portfolio is diversified by geography, industry sub-sector and investment size with no single investment in a company normally accounting for more than 15% of the portfolio at the time of investment. The portfolio is split between large, mid and small-capitalisation companies, primarily quoted on stock exchanges in North America, where the most established and commercial biotech and other life sciences companies and companies operating in related sectors are based, though investments will also be made in Europe, Asia and Australia. Investments may also be made into unquoted companies and into funds not quoted on a stock exchange, including venture capital funds. This may include funds managed by the Investment Manager and/or members of its group. The primary purpose of investment in unquoted funds will be to gain exposure to unquoted companies. The Company may invest through equities, index-linked securities and debt securities, cash deposits, money market instruments and foreign currency exchange transactions. Forward or derivative transactions are not used by the Company. The Company may borrow from time to time to exploit specific investment opportunities, rather than to apply long-term structural gearing to the Company’s portfolio of investments.Read More… Remove Ads Receive IBT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for International Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Email Address IBT Stock News HeadlinesIntuitive BioTechnologies has Expanded Testing CapabilitiesFebruary 6, 2025 | tmcnet.comUpstream Bio, two other U.S. biotech startups price IPOs as healthcare listings riseOctober 11, 2024 | reuters.comTrump… a socialist? Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.April 1, 2025 | Porter & Company (Ad)Oxford BioDynamics Plc (OBD.L) Stock Price, News, Quote & History - Yahoo FinanceSeptember 23, 2024 | finance.yahoo.comPresentation at the 2024 International HBV Meeting Highlights Antiviral Activity of EBT-107 as a Potential Anti-HBV TherapySeptember 17, 2024 | markets.businessinsider.comUK firms fear tougher employment regulation, CBI saysSeptember 16, 2024 | reuters.comSan Jacinto College announces innovative biotechnology program to grow talent pipelineSeptember 16, 2024 | bizjournals.comBirmingham deemed “global leader in AI-driven biotech” by government officialSeptember 10, 2024 | bizjournals.comSee More Headlines IBT Stock Analysis - Frequently Asked Questions How have IBT shares performed this year? International Biotechnology's stock was trading at GBX 682 at the beginning of 2025. Since then, IBT stock has decreased by 10.6% and is now trading at GBX 610. View the best growth stocks for 2025 here. How were International Biotechnology's earnings last quarter? International Biotechnology (LON:IBT) released its earnings results on Tuesday, November, 5th. The company reported ($9.16) EPS for the quarter. International Biotechnology had a net margin of 90.66% and a trailing twelve-month return on equity of 13.67%. How do I buy shares of International Biotechnology? Shares of IBT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of International Biotechnology own? Based on aggregate information from My MarketBeat watchlists, some other companies that International Biotechnology investors own include Vanquis Banking Group (PFG), 1724525 (ADN.L) (ADN), abrdn New India Investment Trust (ANII), The Berkeley Group (BKG), GLI Finance (GLIF), Hurricane Energy (HUR) and Oxford Pharmascience Group (OXP). Company Calendar Last Earnings11/05/2024Record date for 1/24 Dividend12/19/2024Ex-Dividend for 1/24 Dividend12/19/2024Dividend Payable1/24/2025Today4/01/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorFinancial Services Industry Asset Management Sub-IndustryN/A Current SymbolLON:IBT CIKN/A Webwww.ibtplc.com Phone44 20 7421 7070FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX 104.80 Trailing P/E Ratio5.82 Forward P/E Ratio646.46 P/E GrowthN/ANet Income£37.91 million Net Margins90.66% Pretax MarginN/A Return on Equity13.67% Return on Assets3.57% Debt Debt-to-Equity Ratio8.09 Current RatioN/A Quick Ratio0.32 Sales & Book Value Annual Sales£41.82 million Price / Sales5.24 Cash FlowGBX 3.92 per share Price / Cash Flow155.74 Book ValueGBX 766.24 per share Price / Book0.80Miscellaneous Outstanding Shares35,921,299Free FloatN/AMarket Cap£219.12 million OptionableNot Optionable Beta0.21 The 10 Best Stocks to Own: Spring 2025Discover the 10 best stocks to own in Spring 2025, carefully selected for their growth potential amid market volatility. This exclusive report highlights top companies poised to thrive in uncertain economic conditions—download now to gain an investing edge.Get This Free Report This page (LON:IBT) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | SponsoredLive Footage From Elon Musk’s “Area 51”What’s happening inside this nondescript building in South Memphis is so incredible… That Elon’s competitor...Brownstone Research | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | Sponsored“Massive Financial Reset Is Coming”The U.S. markets will see a massive reset, beginning days from now. But the "reset" isn't what you might ex...InvestorPlace | SponsoredGold Hits $3,000… Here’s How You Can Get More for Under $20With gold surging to record highs, currently trading above $3,000 an ounce, and central banks aggressively sto...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding International Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share International Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.